Three years after COVID-19, no significant excess of olfactory or gustatory dysfunction seen in cases versus controls
Rates of Irritable Bowel Syndrome Increased After COVID-19 Hospitalization
Rate of patients fulfilling criteria for depression was also higher for COVID-19 patients versus controls
Risk for GI Disorders Increased After Acute Phase of COVID-19
Risks were seen in patients who were not hospitalized, and increased across the severity spectrum of acute COVID-19
Alterations in Gut Microbiome ID’d in Postacute COVID-19 Syndrome
Higher levels of Ruminococcus gnavus, Bacteroides vulgatus, lower levels of Faecalibacterium prausnitzii observed in patients with PACS
Factors ID’d for Severe GI Effects of SARS-CoV-2 in Children
Among children infected with SARS-CoV-2, 9.5 percent have severe GI effects, such as disseminated adenomesenteritis, appendicitis, pancreatitis
Some Hospitalized COVID-19 Patients Have Ongoing GI Symptoms
Malnutrition is the most persistent GI symptom up to six months following hospitalization
Most Severe Effects of PIMS-TS Resolved at Six Months
Findings generally favorable for patients with pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2
DDW: Alcohol-Related GI, Liver Diseases Up During Pandemic
Demand increased for inpatient consults, inpatient endoscopic interventions for alcohol-related GI, liver diseases, particularly alcoholic hepatitis
- Page 1 of 2
- 1
- 2